• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Testosterone
Date Designated: 09/22/1997
Orphan Designation: For use as physiologic testosterone replacement in androgen deficient HIV+ patients with an associated weight loss.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Watson Laboratories
Research Park
417 Wakara Way
Salt Lake City, Utah 84108
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-